>>Proteins>> Recombinant Proteins>> Superoxide Dismutase>>Cu-ATSM

Cu-ATSM (Synonyms: copper-ATSM, CuII(atsm))

Catalog No.GC43329

Cu-ATSM은 매우 강력한 라디칼 포획 항산화제(RTA)이자 (인지질)지질 과산화의 억제제이므로 페로프토시스를 억제하는 능력을 설명합니다.

Products are for research use only. Not for human use. We do not sell to patients.

Cu-ATSM Chemical Structure

Cas No.: 68341-09-3

Size 가격 재고 수량
1mg
US$28.00
재고 있음
5mg
US$83.00
재고 있음
10mg
US$144.00
재고 있음
25mg
US$315.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The metallo-protein Cu/Zn-superoxide dismutase (SOD1) is a ubiquitous enzyme responsible for scavenging superoxide radicals. Mutations in SOD1, which alter its metal binding capacity and can result in protein misfolding and aggregation, have been linked to familial amyotrophic lateral sclerosis (ALS). Cu-ATSM is an orally bioavailable, blood-brain barrier permeable complex that has traditionally been used in cellular imaging experiments to selectively label hypoxic tissue via its susceptibility to reduction by oxygen-depleted mitochondria. More recently, Cu-ATSM has been reported to improve locomotor function and survival in a transgenic ALS mouse model by delivering copper specifically to cells in the spinal cords of mice producing misfolded SOD1 proteins. Copper chaperone for SOD (CCS) is presumed to utilize the copper from Cu-ATSM to prevent misfolding of the SOD1 protein.

리뷰

Review for Cu-ATSM

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cu-ATSM

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.